+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Hysteroscopy Procedures Market Size, Share and Growth Outlook, 2026: Analysis By Procedure Type (Diagnostic Hysteroscopy, Polypectomy , Myomectomy, IUD , Endometrial Ablation, Tubal Cannulation ), By End-User (Hospitals & Gynecology Surgery Suites, Specialized Women's Health Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Hysteroscopy Procedures Market size is forecast to increase from $5.71 Billion in 2026 to $10.49 Billion in 2034 at a CAGR of 7.9% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007767
Pages: 216 Pages

Hysteroscopy Instruments Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Hysteroscopes , Resectoscopes, Fluid Management Systems, Handheld Instruments , Hysterosheaths, Hysteroscopic Tissue Removal Systems), By Usability (Reusable Instruments, Disposable), By Application (Diagnostic Hysteroscopy, Operative Hysteroscopy ), By End-User (Hospitals & Surgical Suites, Ambulatory Surgery Centers , Office-based Gynecology Clinics) Companies, and Country Forecast, 2021 to 2034

Global Hysteroscopy Instruments Market size is forecast to increase from $2.58 Billion in 2026 to $4.6 Billion in 2034 at a CAGR of 7.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007766
Pages: 219 Pages

Hysterometers Market Size, Share and Growth Outlook, 2026: Analysis By Type (Disposable Hysterometers , Reusable Hysterometers ), By Material (Plastic, Stainless Steel, Flexible), By Technology Integration (Standard Manual Hysterometers, Digital, Ultrasound-Guided Integrated Devices), By End-User (Hospitals, Gynecology & Fertility Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Hysterometers Market size is forecast to increase from $858.18 Million in 2026 to $1337.14 Million in 2034 at a CAGR of 5.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007765
Pages: 223 Pages

Hypoxia Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Type (Hypoxic Hypoxia, Anaemic Hypoxia, Stagnant Hypoxia, Histotoxic Hypoxia), By Treatment Modality (Oxygen Therapy , Pharmacological Treatment , Mechanical Ventilation & Airway Management, Hypoxia Chambers & Simulation Systems), By Disease Indication (Respiratory Diseases , Cardiovascular Conditions , Sleep Disorders , Neonatal Care), By End-User (Hospitals & Critical Care Units, Specialty Clinics, Biopharmaceutical Research Laboratories, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Hypoxia Treatment Market size is forecast to increase from $97.18 Million in 2026 to $150.28 Million in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007764
Pages: 228 Pages

Hypothyroidism Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Primary Hypothyroidism, Secondary Hypothyroidism, Others), By Therapeutic Class (Thyroid Hormone Receptor Agonists, Levothyroxine Sodium, Liothyronine, Combination Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hypothyroidism Market size is forecast to increase from $4.11 Billion in 2026 to $6.26 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007763
Pages: 222 Pages

Hypoparathyroidism Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Hormone Replacement Therapy, Calcium Supplements, Vitamin D Supplements, Others), By Type (Iatrogenic Hypoparathyroidism, Idiopathic Hypoparathyroidism, Others), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hypoparathyroidism Market size is forecast to increase from $1027.48 Million in 2026 to $3056.68 Million in 2034 at a CAGR of 14.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007762
Pages: 219 Pages

Hypogonadism Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Therapy Type (Testosterone Replacement Therapy, Gonadotropin-Releasing Hormone Therapy), By Route of Administration (Injectable, Topical , Oral, Implantable), By Application (Klinefelter Syndrome, Kallmann Syndrome, Pituitary Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hypogonadism Treatment Market size is forecast to increase from $3.93 Billion in 2026 to $6.46 Billion in 2034 at a CAGR of 6.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007761
Pages: 213 Pages

Hypodermic Needles Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Safety Hypodermic Needles, Non-Safety Hypodermic Needles), By Gauge Size (Less than 18G, 18G–22G, Greater than 22G), By Application (Drug Delivery, Vaccination, Blood Collection), By End User (Hospitals & Ambulatory Surgery Centers, Diagnostic & Pathology Centers, Home Healthcare & Self-Injection Settings) Companies, and Country Forecast, 2021 to 2034

Global Hypodermic Needles Market size is forecast to increase from $3.93 Billion in 2026 to $5.22 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007760
Pages: 229 Pages

Hypertrophic Cardiomyopathy Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Beta-Adrenergic Blocking Agents, Calcium Channel Blockers, Cardiac Myosin Inhibitors, Antiarrhythmic Agents, Anticoagulants), By Disease Phenotype (Obstructive Hypertrophic Cardiomyopathy, Non-Obstructive Hypertrophic Cardiomyopathy), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hypertrophic Cardiomyopathy Therapeutics Market size is forecast to increase from $830.58 Million in 2026 to $996.29 Million in 2034 at a CAGR of 2.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007758
Pages: 230 Pages